Politiparty
Politiparty

118th Congress Health

S. 1373: Naloxone Affordability Act of 2023

Introduced

  1. Introduced (completed)Apr 27, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Apr 27, 2023

This bill requires the Government Accountability Office to study health insurance coverage and out-of-pocket costs for naloxone as an over-the-counter medication.

Naloxone is a medication that temporarily reverses opioid overdoses. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved a naloxone nasal spray (sold under the brand name Narcan) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

3

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Edward Markey D-MA SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Edward Markey

History

  1. Apr 27, 2023Introduced in the Senate by Edward Markey.
Show the full action history (2 actions)
  1. Apr 27, 2023Introduced in Senate
  2. Apr 27, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.